About This 510(k) Submission
K193393 is an FDA 510(k) clearance for the BOND Ready-to-Use Primary Antibody Progesterone Receptor (16), Novocastra Liquid Mouse Monoclonal Antibody Progesterone Receptor Clone 16 (Concentrated Liquid Antibody Format)., a Immunohistochemistry Assay, Antibody, Progesterone Receptor (Class II — Special Controls, product code MXZ), submitted by Leica Biosystems Newcastle, Ltd. (Newcastle Upon Tyne, GB). The FDA issued a Cleared decision on March 6, 2020, 91 days after receiving the submission on December 6, 2019. This device falls under the Pathology review panel. Regulated under 21 CFR 864.1860.